VRTX Working Capital Ratio
Vertex Pharmaceuticals · Working Capital Ratio

VRTX Working Capital Ratio
Latest reported28.08%period ending
VRTX FY Working Capital Ratio (32.61% → 28.08%)
Annual working capital ratio
High-resolution chart · PNG
VRTX working capital ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 28.0758% | |
| 26.7685% | |
| 46.6199% | |
| 57.8082% | |
| 55.2287% | |
| 53.2335% | |
| 41.9308% | |
| 43.5937% | |
| 51.9373% | |
| 35.9046% | |
| 36.0821% | |
| 50.4324% | |
| 51.3465% | |
| 41.9297% | |
| 42.5947% | |
| 33.7452% | |
| 52.2703% | |
| 66.3979% | |
| 49.4735% | |
| 56.4674% | |
| 51.8785% | |
| 45.2638% | |
| 62.7736% | |
| 72.5709% | |
| 73.9937% | |
| 56.0804% | |
| 76.0237% | |
| 88.4716% | |
| 90.6292% | |
| 87.1777% | |
| 79.899% | |
| 86.833% | |
| 75.082% | |
| 78.6275% | |
| 85.8144% | |
| 32.6087% |